Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Krantz

Showing results (111-120 of 121) with videos related to

Pageof 13
Sort By:
Transplant Infectious Disease : an Official Journal of the Transplantation Society|January 9, 2024
Clinical outcomes and frequency of persistent infection among immunosuppressed patients treated with bebtelovimab for COVID-19 infection at an ambulatory cancer centerEduardo Sanchez, Elizabeth M Krantz, Leah Yoke, et al.
Blood Advances|September 12, 2022
Humoral and cellular responses to SARS-CoV-2 vaccines before and after chimeric antigen receptor-modified T-cell therapyMichael A Gonzalez, Atif M Bhatti, Kristin Fitzpatrick, et al.
Pediatric Blood & Cancer|June 4, 2019
Survival of children with endemic Burkitt lymphoma in a prospective clinical care project in UgandaSuzanne M McGoldrick, Innocent Mutyaba, Scott V Adams, et al.
Microbiology Spectrum|April 27, 2026
Assessing VirScan serosurvey epitope profiling variability between in-clinic venous blood draw and capillary blood self-sampling deviceLinda M Sircy, Terry L Stevens-Ayers, Elizabeth M Krantz, et al.
JCI Insight|April 29, 2021
Antibodies against vaccine-preventable infections after CAR-T cell therapy for B cell malignanciesCarla S Walti, Elizabeth M Krantz, Joyce Maalouf, et al.
Nature Communications|April 6, 2026
Influence of B cell-lineage targeted CAR-T cell therapy on humoral immunity and vaccine-induced antibody responseStosh Ozog, Elizabeth M Krantz, Karyn Tindbaek, et al.
Medrxiv : the Preprint Server for Health Sciences|May 20, 2021
Humoral immunogenicity of the seasonal influenza vaccine before and after CAR-T-cell therapyCarla S Walti, Andrea N Loes, Kiel Shuey, et al.
Blood|April 18, 2024
Human herpesvirus 6 reactivation and disease are infrequent in chimeric antigen receptor T-cell therapy recipientsEleftheria Kampouri, Elizabeth M Krantz, Hu Xie, et al.
Journal for Immunotherapy of Cancer|October 27, 2021
Humoral immunogenicity of the seasonal influenza vaccine before and after CAR-T-cell therapy: a prospective observational studyCarla S Walti, Andrea N Loes, Kiel Shuey, et al.
Medrxiv : the Preprint Server for Health Sciences|October 1, 2025
Multiplex serology reveals age-specific immunodynamics of endemic respiratory pathogens in the wake of the COVID-19 pandemicSamantha J Bents, Emily T Martin, Terry Steven-Ayers, et al.
Pageof 13

Showing results (111-120 of 121) with videos related to

Sort By:
Pageof 13
Transplant Infectious Disease : an Official Journal of the Transplantation Society|January 9, 2024
Clinical outcomes and frequency of persistent infection among immunosuppressed patients treated with bebtelovimab for COVID-19 infection at an ambulatory cancer centerEduardo Sanchez, Elizabeth M Krantz, Leah Yoke, et al.
Blood Advances|September 12, 2022
Humoral and cellular responses to SARS-CoV-2 vaccines before and after chimeric antigen receptor-modified T-cell therapyMichael A Gonzalez, Atif M Bhatti, Kristin Fitzpatrick, et al.
Pediatric Blood & Cancer|June 4, 2019
Survival of children with endemic Burkitt lymphoma in a prospective clinical care project in UgandaSuzanne M McGoldrick, Innocent Mutyaba, Scott V Adams, et al.
Microbiology Spectrum|April 27, 2026
Assessing VirScan serosurvey epitope profiling variability between in-clinic venous blood draw and capillary blood self-sampling deviceLinda M Sircy, Terry L Stevens-Ayers, Elizabeth M Krantz, et al.
JCI Insight|April 29, 2021
Antibodies against vaccine-preventable infections after CAR-T cell therapy for B cell malignanciesCarla S Walti, Elizabeth M Krantz, Joyce Maalouf, et al.
Nature Communications|April 6, 2026
Influence of B cell-lineage targeted CAR-T cell therapy on humoral immunity and vaccine-induced antibody responseStosh Ozog, Elizabeth M Krantz, Karyn Tindbaek, et al.
Medrxiv : the Preprint Server for Health Sciences|May 20, 2021
Humoral immunogenicity of the seasonal influenza vaccine before and after CAR-T-cell therapyCarla S Walti, Andrea N Loes, Kiel Shuey, et al.
Blood|April 18, 2024
Human herpesvirus 6 reactivation and disease are infrequent in chimeric antigen receptor T-cell therapy recipientsEleftheria Kampouri, Elizabeth M Krantz, Hu Xie, et al.
Journal for Immunotherapy of Cancer|October 27, 2021
Humoral immunogenicity of the seasonal influenza vaccine before and after CAR-T-cell therapy: a prospective observational studyCarla S Walti, Andrea N Loes, Kiel Shuey, et al.
Medrxiv : the Preprint Server for Health Sciences|October 1, 2025
Multiplex serology reveals age-specific immunodynamics of endemic respiratory pathogens in the wake of the COVID-19 pandemicSamantha J Bents, Emily T Martin, Terry Steven-Ayers, et al.
Pageof 13